X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

China Active Pharmaceutical Ingredients (API) Companies (2024 - 2029)

Various companies in the pharmaceutical industry are making significant strides in their respective fields. These businesses, which range from well-established corporations to emerging start-ups, are developing innovative solutions and products to address a variety of health-related issues. Their work includes the production of pharmaceuticals, the development of new medical technologies, and the provision of various healthcare services. The industry is highly competitive, with companies constantly striving to outperform their rivals and gain a larger share of the market. Despite the challenges, these firms continue to thrive and contribute significantly to the global healthcare sector.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research China Active Pharmaceutical Ingredients (API) Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in China Active Pharmaceutical Ingredients (API) Market

This report lists the top China Active Pharmaceutical Ingredients (API) companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the China Active Pharmaceutical Ingredients (API) industry.

  1. WuXi App Tec

  2. Asymchem Laboratories

  3. Reyoung Pharmaceutical

  4. Zhejiang NHU

  5. CSPC Pharmaceutical Group

*Disclaimer: Top companies sorted in no particular order

China Active Pharmaceutical Ingredients (API) Market Major Players

China Active Pharmaceutical Ingredients (API) Market Concentration

China Active Pharmaceutical Ingredients (API) Market Concentration

China Active Pharmaceutical Ingredients (API) Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions & Market Definition

    2. 1.2 Scope Of The Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Infectious, Genetic, Cardiovascular, and Other Chronic Diseases

      2. 4.2.2 Rising Prevalence of Cancer and Increasing Sophistication in Oncology Drug Research

    3. 4.3 Market Restraints

      1. 4.3.1 High Competition between API Manufacturers

      2. 4.3.2 Stringent Regulations and Drug Price Policies in the Country

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Business Mode

      1. 5.1.1 Captive API

      2. 5.1.2 Merchant API

    2. 5.2 By Synthesis Type

      1. 5.2.1 Synthetic

      2. 5.2.2 Biotech

    3. 5.3 By Drug Type

      1. 5.3.1 Generic

      2. 5.3.2 Branded

    4. 5.4 By Application

      1. 5.4.1 Cardiology

      2. 5.4.2 Oncology

      3. 5.4.3 Pulmonology

      4. 5.4.4 Neurology

      5. 5.4.5 Orthopedic

      6. 5.4.6 Ophthalmology

      7. 5.4.7 Other Applications

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Zhejiang Hisun Pharmaceutical

      2. 6.1.2 Zhejiang NHU Co., Ltd

      3. 6.1.3 Hengdian Group

      4. 6.1.4 CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co., Ltd)

      5. 6.1.5 Shandong Xinhua Pharmaceutical Group Co., Ltd

      6. 6.1.6 WuXi AppTec (WuXi STA)

      7. 6.1.7 Asymchem Laboratories

      8. 6.1.8 Reyoung Pharmaceutical

      9. 6.1.9 Zhe Jiang Hua Hai Pharmaceutical Co., Ltd

      10. 6.1.10 Foodchem International Corporation

      11. 6.1.11 Sinopharm

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to China Active Pharmaceutical Ingredients (API) Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

China Active Pharmaceutical Ingredients (API) Market Companies Summary

The Chinese Active Pharmaceutical Ingredients (API) market experienced disruption due to the COVID-19 pandemic, which affected the supply chain and restricted manufacturers from supplying APIs to various countries. However, the easing of restrictions and resumption of import-export activities are expected to increase the export of APIs and drugs to different countries, enhancing market growth. The market growth is also being driven by the rising prevalence of chronic, infectious, and genetic diseases, the increasing prevalence of cancer, advancements in oncology drug research, and the growing geriatric population. Several firms are focusing on improving API production to meet rising global demands, which is expected to boost the market. Additionally, the increase in people affected by various infectious, genetic, cardiovascular, and other chronic diseases is expected to increase the demand for API production. This has led to companies focusing on developing advanced and safe drugs, which require a large amount of API, propelling the market growth. The rising geriatric population, more prone to develop chronic diseases, is also expected to increase market growth. Furthermore, companies are adopting various business strategies, such as agreements and collaborations, as well as rising product approvals, contributing to market growth. The expansion and construction of API manufacturing facilities are also contributing to market growth. However, stringent regulations for drug approvals and drug price policies are expected to hinder market growth.

Explore More

China Active Pharmaceutical Ingredients (API) Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 Zhejiang Hisun Pharmaceutical

      2. 1.1.2 Zhejiang NHU Co., Ltd

      3. 1.1.3 Hengdian Group

      4. 1.1.4 CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co., Ltd)

      5. 1.1.5 Shandong Xinhua Pharmaceutical Group Co., Ltd

      6. 1.1.6 WuXi AppTec (WuXi STA)

      7. 1.1.7 Asymchem Laboratories

      8. 1.1.8 Reyoung Pharmaceutical

      9. 1.1.9 Zhe Jiang Hua Hai Pharmaceutical Co., Ltd

      10. 1.1.10 Foodchem International Corporation

      11. 1.1.11 Sinopharm

    2. *List Not Exhaustive

China Active Pharmaceutical Ingredients (API) Companies FAQs

WuXi AppTec (WuXi STA), Asymchem Laboratories, Reyoung Pharmaceutical, Zhejiang NHU Co., Ltd. and CSPC Pharmaceutical Group Limited (Shijiazhuang Pharmaceutical Group Co., Ltd) are the major companies operating in the China Active Pharmaceutical Ingredients (API) Market.

China Active Pharmaceutical Ingredients (API) Report Snapshots

China Active Pharmaceutical Ingredients (API) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)